Home
Test Susistainable development goals
We champion the rights of ALL children to a good quality of life and a healthy, prosperous future.
Sustainability is a key priority for the Pediatric Praziquantel Consortium and the United Nations (UN) Sustainable Development Goals (SDGs) are the foundation of our strategy.
Neglected tropical diseases (NTDs), including schistosomiasis, are formally recognized as targets for global action under SDG 3 (Good Health and Wellbeing). Specifically, target 3.3., calls to “end the epidemics of AIDS, tuberculosis, malaria and neglected tropical diseases…” to “ensure healthy lives and promote well-being for all at all ages”. As such, only once all NTD goals are met, can the SDGs be achieved.
Our contribution to the achievement of the SDGs
Through our work to develop, register, and provide access to a potential new treatment option for preschool-aged children (3 months to 6 years of age) infected with schistosomiasis, we aim to contribute to the elimination of schistosomiasis as a public health problem.
Diseases of poverty, like schistosomiasis, must be overcome in order to deliver on the SDGs and ensure universal health coverage.
Dr Michael Makanga, Executive Director of the European & Developing Countries Clinical Trials Partnership (EDCTP)Successful development and access to a suitable pediatric treatment for schistosomiasis – through this global public-private partnership – is a tangible contribution towards the Sustainable Development Goals by ensuring that the preschool-age group is not left behind.
-
SDG 2: Zero hunger
Schistosomiasis has been linked with malnutrition, stunting, and anemia. By treating preschool-aged children we contribute to ending malnutrition.
SDG 3: Good Health and Wellbeing
Through our work to support the elimination of schistosomiasis, we are helping to ensure healthy lives and promote well-being for all at all ages. Treating schistosomiasis at an early age will address a child health development challenge that will have a positive impact on pediatric public health programs in general.
SDG 9: Industry, Innovation, and Infrastructure
We integrate initiatives to enhance health capacity in developing countries through new infrastructure, training of local healthcare professionals, and sustainable & affordable manufacturing capacity for local production.
SDG 17: Partnerships for the Goals
Partnerships are key to addressing global health challenges. Established in 2012 as the first international, non-profit, public-private partnership in schistosomiasis, we operate through an innovative approach that has engaged new partners and collaborators as required.
Indirect contributions
-
SDG 1: No Poverty
Treating preschool-aged children as part of a wider approach to eliminating schistosomiasis will contribute to breaking the cycle of poverty.
SDG 4: Quality Education
We champion the rights of ALL children to a good quality of life and a healthy, prosperous future. Left untreated, schistosomiasis can lead to anemia, stunted growth, as well as reduced learning ability due to cognitive impairment.
SDG 8: Decent Work and Economic Growth
We indirectly contribute to SDG 8 through our health capacity initiatives by favoring employment and economic productivity.